Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by BearDownAZon Jul 07, 2015 2:56pm

103 Views

Post# 23899650

RE:RE:RE:RE:scam mb just exposed...read and laugh

G1945V, It sounds like you like the way things are here at SH. The other hub is run differently and has higher standards, set rules (https://agoracom.com/help-center/six_rules) and mechanisms to remove posts/posters that violate those set rules. It is not so much censorship as it is enforcement and maintaining of high standards. The poster in question was in clear violation of rule #5 on the other hub. Regardless, let's all hope that tomorrow goes as we all hope with Hepalink

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale